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Fractional Blister Grafting for Non-Healing Burn Wounds
• Blister grafts have been shown to be effective in 
promoting re-epithelialization in wound sites that other 
treatments had failed to help close.1-3 The method for 
blister grafting to treat pigmentation diseases was first 
described in 1964.4
• The cellutome™ automated harvesting system was 
first introduced to the US market in 2013. We started 
using the cellutome™ blister grafting procedure in 
September 2015.
• The procedure is done in the outpatient setting. This 
reduces patient anxiety and the perceived set-back of 
returning to the OR and possible hospital re-admission.
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• Non-healing burn wounds can pose a significant 
obstacle to the healing and rehabilitation of those that 
have suffered larger surface area burns. Most of the 
wounds seen in this series were located on the lower 
extremities and feet. Epidermal autografting
significantly reduced the time that a small, chronic 
wound took to heal. However, the presence of a 
comorbidity significantly reduced the likelihood of the 
wound healing. Pain during the procedure was 
reported as minimal and donor sites did not develop 
complications in this series.
• We examined the charts of all patients treated in the 
burn center with this device for non-healing wounds in 
a retrospective review
• Data collected was: age, gender, wound etiology, 
wound location, comorbidities, duration of wound from 
presentation to cellutome™ procedure, wound healing 
time, percent epithelialization 6 weeks post-procedure, 
donor site healing time, complications at wound or 
donor site, pain during procedure, hospital charges, 
costs of dressings
– Comorbidities defined as diabetes, vascular disease, obesity, 
symptomatic CAD, immunosuppression
• Blister grafting is an effective, time-saving, and 
minimally invasive alternative to split thickness skin 
grafting. Patient compliance and reduction of 
comorbidities cannot be controlled in the outpatient 
setting, but produce significant effects on the outcomes 
of wound treatment.






Figure 1: Automated epidermal 
graft harvester with raised 
blisters inside suction chamber.
Figure 3: Donor site
immediately post-procedure 
before tegaderm was applied.
RESULTS
• 37 patients met the inclusion criteria
• Mean age was 54.7±20.9 years, 59.5% were male
• 81% of wounds in this series were burn wounds, 1 
diabetic foot wound, 3 trauma wounds, 3 vasculitis 
sores
• Majority of wounds were located on the lower 
extremities (64.8%) and feet (24.3%)
• Mean wound duration from presentation to the 
epidermal autografting procedure was 93.0±78.9 days
• 81% of wounds healed successfully
– In all cases of a wound failing to heal, patient suffered from one or 
more comorbidities.
• Mean wound healing time was 43.9±23.4 days (range 
21-125)
– 65% of subjects were at or near full epithelialization (>95%) six 
weeks post-procedure
– 24.3% developed complications at the wound  site
• Donor sites did not develop complications and took a 
mean of 12.8±6.3 days to heal
• Pain during the procedure was nearly unanimously 
reported as a 0 on the Lickert scale. One patient 
reported a rating of 3
















Figure 2: Individual blisters 
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